Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-03-01, Stock:ABT, The news for the past five days is as follows:
2018-02-22: NEWS1: Abbott Laboratories: ABT Stock’s Wall Street Recommendations.NEWS2: Abbott Laboratories’ Breast Cancer Study with Angle.NEWS3: Abbott Laboratories’ LibreLink App in Europe.NEWS4: Abbott Laboratories’ 377th Consecutive Quarterly Dividend.NEWS5: [$$] Union claims success at start of strike by UK university lecturers.
2018-02-23: NEWS1: Abbott (ABT) Down 6.7% Since Earnings Report: Can It Rebound?.NEWS2: Abbott (ABT) Down 6.7% Since Earnings Report: Can It Rebound?.NEWS3: Abbott (ABT) Down 6.7% Since Earnings Report: Can It Rebound?.NEWS4: IUSG, MCD, ABT, AMGN: ETF Inflow Alert.NEWS5: IUSG, MCD, ABT, AMGN: ETF Inflow Alert.NEWS6: Abbott Laboratories’ Stock Performance after a Recent Bull Run.
2018-02-26: NEWS1: How Tax Reform Affected Medtronic’s 3Q18 Performance.NEWS2: Medtronic Recovers from 1H18 Disasters with Robust 3Q18 Sales.NEWS3: What Analysts Recommend for Medtronic, Post-3Q18 Results.NEWS4: George Soros Just Bought These 2 Biotech Stocks. Should You?.NEWS5: George Soros Just Bought These 2 Biotech Stocks. Should You?.NEWS6: George Soros Just Bought These 2 Biotech Stocks. Should You?.
2018-02-27: NEWS1: Surmodics, Abbott ink licensing deal worth up to $92M.NEWS2: Mid-Day Update: Stocks Turn Negative as Powell Spooks Wall Street With Hint of Four Rate Hikes.NEWS3: Mid-Day Update: Stocks Turn Negative as Powell Spooks Wall Street With Hint of Four Rate Hikes.NEWS4: Medtronic’s Updated 2018 Guidance.NEWS5: Stay Long Abbott Labs' Investors.NEWS6: Medtronic’s Minimally Invasive Therapies Group in 3Q18.NEWS7: Abbott and Surmodics Announce Agreement for Next-Generation Drug-Coated Balloon.NEWS8: What Drove Medtronic’s Cardiac and Vascular Group in 3Q18.
2018-02-28: NEWS1: MedTech&apos;s Long-Term Prospects Outweigh Near-Term Risks.NEWS2: Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic, Covidien and Smith & Nephew, Abbott Labs and Boston Scientific.NEWS3: Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic, Covidien and Smith & Nephew, Abbott Labs and Boston Scientific.NEWS4: Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic, Covidien and Smith & Nephew, Abbott Labs and Boston Scientific.

Answer: Decrease